Recent articles
Here's Why Zogenix Shares Rose as Much as 23.8% Today
The company cleared up an issue with the FDA.
Is Alliance Resource Partners a Buy?
The coal producer sports an eye-popping 12.6% distribution yield, but does coal belong in your portfolio?
Why Palatin Technologies Stock Dropped as Much as 21.5% Today
A high-profile analyst questioned the company's recent FDA approval.
Here's the Surprising Reason ArQule Shares Rose as Much as 11% Today
Investors are increasingly optimistic about the company.
Here's Why New Gold Rose as Much as 14.6% Today
Much like gold prices, the gold miner is on the up-and-up.
3 Dividend Stocks Ideal for Retirees
Investors in their later years might want to give these income payers a closer look.
Enphase Energy: Buy at the High?
A 273% year-to-date return has this solar stock trading at an all-time high.
3 Under-the-Radar but Amazing Dividend Stocks
Sometimes the best income stocks are the ones that go unnoticed.
2 Stocks to Buy With Dividends Yielding More Than 3%
Investors seeking income might want to give a hard look at this oil supermajor and leading pulp and paper manufacturer.
I Tracked Every Car-Related Expense for 6 Years. Here's What I Learned.
What's the true cost of car ownership? This data can help provide insight.
U.S. Silica Has an Unlikely Growth Opportunity: Cool Roofs
Energy-efficient roofing materials just might be the industrial application U.S. Silica shareholders have been waiting for.
3 Growth Stocks for In-the-Know Investors
These stocks could help take your portfolio to the next level.
Here's Why Gold Stocks Rose as Much as 15.3% Today
Comments from the U.S. central bank pushed gold prices to nearly $1,400 per ounce.
Here's Why Green Plains Fell as Much as 12.5% Today
The business suspended its dividend. While that's not exactly a surprising move, it highlights the sour financial position of the ethanol leader.
Here's Why Unity Biotechnology Dropped as Much as 20.4% Today
The longevity-focused biopharma delivered mixed results in its first clinical trial in humans.
2 Top Stocks Under $10
Investors have had to withstand above-average volatility with these two stocks in recent years, but better days are on the horizon.
Here's Why ArQule Is Soaring Again Today
A new day, a new batch of promising interim data from an early-stage clinical study.
Better Buy: Albemarle vs. Pattern Energy
The lithium producer has big growth plans, but the renewable power asset manager has ambitions of its own.
Here's Why ArQule Shares Rose as Much as 44.7% Today
The stock soared to its highest level in over 10 years on encouraging, early-stage clinical results.
Here's Why Savara Pharmaceuticals Collapsed Today
Investors just received some bad news about the company's lead drug candidate.